1 - Anemia process measureOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all pediatric (<18 years old) hemodialysis and peritoneal dialysis patients prescribed an ESA at any time during the study period or who have a Hb<11.0 g/dL in at least one month of the study period for whom serum ferritin concentration and percent transferrin saturation (TSAT) are measured at least once in a three-month period
Type: Process
2 - Assessment of Iron StoresOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all adult (>= 18 years old) dialysis patients for whom serum ferritin and TSAT are measured simultaneously at least once during the three-month study period.
Type: Process
3 - Avoidance of Iron Therapy in Iron OverloadOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all adult (>= 18 years old) dialysis patients with a serum ferritin >= 1200 ng/mL or a TSAT >= 50% on at least one simultaneous measurement during the three-month study period who did not receive IV iron in the following three months.
Type: Process
4 - Bacteremia (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of bacteremia among adult chronic HD patients prescribed IV antibiotics
Type: Process
5 - Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate of bacteremia with IV antibiotic therapy, among adult chronic HD patients
Type: Process
6 - Catheter-Related Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related bacteremia with IV antibiotic therapy, among adult chronic HD patients using a catheter for hemodialysis access
Type: Process
7 - Catheter-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis catheter-related infection among adult chronic HD patients with a HD access-related infection and prescribed IV antibiotics
Type: Process
8 - Catheter-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related infection with IV antibiotic therapy, among adult chronic HD patients using a catheter for hemodialysis access
Type: Process
9 - Clinically Confirmed Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of clinically confirmed infection among HD patients prescribed IV antibiotics
Type: Process
10 - Clinically Confirmed Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate of clinically confirmed infection with IV antibiotic therapy among adult chronic HD patients
Type: Process
11 - Dietary Sodium Reduction AdviceOrganization: Centers for Medicare & Medicaid Services
Description: The proportion of patients who received formal advice on dietary sodium restriction by the renal dietician within the past 90 days.
Type: Process
12 - Fistula-Related Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related bacteremia with IV antibiotic therapy, among adult chronic HD patients using an arteriovenous fistula for hemodialysis access
Type: Process
13 - Fistula-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis arteriovenous fistula-related infection among adult chronic HD patients with a HD access-related infection and prescribed IV antibiotics
Type: Process
14 - Fistula-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related infection with IV antibiotic therapy, among adult chronic HD patients using an arteriovenous fistula for hemodialysis access
Type: Process
15 - Frequency of hemodialysis adequacy measurementOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all pediatric (<18 years old) patients receiving in-center hemodialysis (irrespective of frequency of dialysis) with documented monthly adequacy measurements (spKt/V) or its components in the calendar month
Type: Process
16 - Graft-Related Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related bacteremia with IV antibiotic therapy, among adult chronic HD patients using an arteriovenous graft for hemodialysis access
Type: Process
17 - Graft-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis arteriovenous graft-related infection among adult chronic HD patients with a HD access-related infection and prescribed IV antibiotics
Type: Process
18 - Graft-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related infection with IV antibiotic therapy, among adult chronic HD patients using an arteriovenous graft for hemodialysis access
Type: Process
19 - Hemoglobin process measureOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all pediatric (<18 years old) hemodialysis patients and peritoneal dialysis patients with ESRD =3 months who have monthly measures for hemoglobin. The hemoglobin value reported for the end of each reporting month (end-of-month hemoglobin) is used for the calculation
Type: Process
20 - Iron therapyOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all pediatric (<18 years old) hemodialysis and peritoneal dialysis patients with hemoglobin<11.0 g/dL and in whom simultaneous values of serum ferritin concentration was <100 ng/ml and TSAT<20% who received IV iron or were prescribed oral iron within the following three months
Type: Process
